Muscle weakness in patients admitted to the Intensive Care Unit lengthens duration of mechanical ventilation, weaning and hospital stay. One of the causes for muscle weakness is critical illness polyneuromyopathy (CIPM). The incidence of CIPM varies…
ID
Bron
Verkorte titel
Aandoening
Critical Illness polyneuromyopathy
ICU-acquired weakness
Critical Illness polyneuromyopathie
electrical stimulation
elektrische zenuwstimulatie
Ondersteuning
Medisch Spectrum Twente, Thoraxcentrum
Haaksbergerstraat 55, 7513 ER Enschede
0534872000
Medisch Spectrum Twente, Thoraxcentrum
Haaksbergerstraat 55, 7513 ER Enschede
0534872000
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Difference in muscle force (percentage) between stimulated and non-stimulated legs on day 1 and day 10.
Achtergrond van het onderzoek
Muscle weakness in patients admitted to the Intensive Care Unit (ICU) lengthens duration of mechanical ventilation, weaning and hospital stay. One of the causes for muscle weakness is critical illness polyneuromyopathy (CIPM). The incidence of CIPM varies between 25 and 100%, depending on patient population, diagnostic criteria and timing of measurements. Despite many previous studies, the pathophysiology and risk factors of CIPM remain unclear. More importantly, there is yet no therapy for this disease. Electrical stimulation has shown to improve muscle strength, cross-sectional area of muscle and prevent muscle atrophy. We hypothesize that electrical stimulation of nerves in patients with CIPM will improve muscle strength.
Patients who are expected to be admitted to the thoracic ICU for longer than 2 days will be included in this study. Some of these patients will develop CIPM. Patients will receive muscle force measurements of the M. extensor hallucis longus on day 0. On day 1-10 muscle force and electrophysiological measurements will take place daily. On day 1-9 electrical stimulation of the N. peroneus communis on one leg will be applied for 30 minutes. Randomization determines which leg will be stimulated (dominant or non-dominant). The primary outcome measure is the difference in muscle force (percentage) between stimulated and non-stimulated legs on day 1 and day 10. Also, electrophysiological measurements will be evaluated.
Doel van het onderzoek
Muscle weakness in patients admitted to the Intensive Care Unit lengthens duration of mechanical ventilation, weaning and hospital stay. One of the causes for muscle weakness is critical illness polyneuromyopathy (CIPM). The incidence of CIPM varies between 25 and 100%, depending on patient population, diagnostic criteria and timing of measurements. Despite many previous studies, the pathophysiology and risk factors of CIPM remain unclear. More importantly, there is yet no therapy for this disease. Electrical stimulation has shown to improve muscle strength, cross-sectional area of muscle and prevent muscle atrophy. We hypothesize that electrical stimulation of nerves in patients with CIPM will improve muscle strength.
Onderzoeksopzet
Patients will receive muscle force measurements of the M. extensor hallucis longus on day 0. On day 1-10 muscle force and electrophysiological measurements will take place daily. On day 1-9 electrical stimulation of the N. peroneus communis will be applied.
Onderzoeksproduct en/of interventie
Electrical nerve stimulation of the N. peroneus communis on one leg. Randomization determines whether the dominant or non-dominant leg is stimulated. Stimulation will be applied daily for 30 minutes on 9 weekdays.
Algemeen / deelnemers
J Vermeijden
Enschede 7513 ER
The Netherlands
+31 (0)534872000
j.vermeijden@ziekenhuis-mst.nl
Wetenschappers
J Vermeijden
Enschede 7513 ER
The Netherlands
+31 (0)534872000
j.vermeijden@ziekenhuis-mst.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Age above 18 years;
2. aortic surgery;
3. mitral valve repair or replacement surgery;
4. double valve surgery;
5. coronary artery surgery with poor left ventricle function;
6. patients scheduled for cardiovascular surgery with chronic kidney failure or kidney-function disorders;
7. COPD patients scheduled for cardiovascular surgery with FEV1 < 1.5 Liter;
8. patients with preexisting pulmonary disorders scheduled for cardiovascular surgery;
9. admission at thoracic ICU;
10. obtained informed consent.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Existing neuropathy or myopathy;
2. not having 4 limbs.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL1508 |
NTR-old | NTR1578 |
Ander register | METC Medisch Spectrum Twente : P08-50 |
ISRCTN | ISRCTN wordt niet meer aangevraagd |